NCT07052175 Prevention of Relapse in Behavioral Disorders
| NCT ID | NCT07052175 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clínica Nuestra Señora de la Paz |
| Condition | Substance-related Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2026-04-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to validate the effectiveness of a digital tool for monitoring and early relapse detection in addiction treatment. It compares outcomes between a traditional multidisciplinary model and the same model enhanced by the technology. The research seeks to demonstrate the tool's added clinical value in improving long-term recovery outcomes.
Eligibility Criteria
Inclusion Criteria: * Understand spoken and written Spanish. * Signing the informed consent. * Own a smartphone with internet access and an iOS or Android operating system. Exclusion Criteria: * Institutionalized or incarcerated patients, or those anticipating imminent incarceration, without regular access to mobile phone use. * Refusal to install the mobile application. * Inability to understand and sign the informed consent form for any reason.
Contact & Investigator
Juan Jesús Muñoz García, PhD
PRINCIPAL INVESTIGATOR
Centro San Juan de Dios de Ciempozuelos
Frequently Asked Questions
Who can join the NCT07052175 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Substance-related Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07052175 currently recruiting?
Yes, NCT07052175 is actively recruiting participants. Contact the research team at rafael.salom@sjd.es for enrollment information.
Where is the NCT07052175 trial being conducted?
This trial is being conducted at Ciempozuelos, Spain, Madrid, Spain.
Who is sponsoring the NCT07052175 clinical trial?
NCT07052175 is sponsored by Clínica Nuestra Señora de la Paz. The principal investigator is Juan Jesús Muñoz García, PhD at Centro San Juan de Dios de Ciempozuelos. The trial plans to enroll 150 participants.